Upgrade to scoring system. Read more.

PGNX - Progenics Pharmaceuticals Inc.

Industry: Biotechnology Sector: Healthcare | Exchange: NASDAQ

Sell Candidate
Buy Score Rank #2546 out of #5176
Fri 18'th Aug 2017

PERIOD COVERED
2017-05-19 - 2017-08-18
CHANGE
-1.76%
PRICE
$5.57
VOLUME
Sell
TREND
Sell

MV LONG
Sell

MV SHORT
Buy

PIVOT
Sell

MACD
Buy

BOLLINGER
Sell
Request Prediction
0.00%

Progenics Pharmaceuticals Inc. Stock Analysis

Technical stock analysis for Fri 18'th Aug 2017

Sell candidate since 2017-08-16 Loss -3.97%

Progenics Pharmaceuticals Inc. fell by -1.76% in the last day from $5.67 to $5.57 and has now fallen 3 days in a row. The price has been going up and down for this period, and there has been a -4.3% loss for the last 2 weeks. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -245 223 shares and in total 771 474 shares bought and sold for approximately $4.30 million.

Trend

Progenics Pharmaceuticals Inc. lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -16.69% during the next 3 months and, with 90% probability hold a price between $4.15 and $5.62 at the end of this period.

Signals

Some negative signals were issued as well, and these may have some influence on the near short-term development. Progenics Pharmaceuticals Inc. holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $6.27. On a fall, the stock will find some support from the short-term average at $5.55. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal. A sales signal was issued from a pivot top point on Wednesday August 16, 2017, which indicates further falls until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Relative Strength Index (RSI)

RSI14 is 43 and the stock is currently not being overbought or oversold

Support & Resistance

Progenics Pharmaceuticals Inc. finds support from accumulated volume at $5.33. On the upside the stock meets some resistance from accumulated volume at $6.69, $6.90 and $6.95.

Support: $5.33 Price: $5.57 Resistance: $6.69
S: $5.33 Price: $5.57 R: $6.69

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.22 between high and low, or 3.99%. For the last week, the stock has had a daily average volatility of 7.04%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High

Overall risk:

           

Evaluation

Progenics Pharmaceuticals Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Sell Candidate

Help StockInvest improve by answering this short survey clicking HERE.

Build Your Watchlist

Add PGNX My Watchlist

Recommended
books of the week

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

Sign up to get FREE access to awesome features

Auto-portfolios that gain up to 30%

Request predictions from other users

Watchlist builder with notifications

News updates from 100+ financial publications

START FREE 5-DAY TRIAL
START FREE 5-DAY TRIAL